Remove trial restrictions ▶ Start for $1

Serving leading biopharmaceutical companies globally:

Mallinckrodt
Medtronic
Johnson and Johnson
Baxter
Merck
Express Scripts

Last Updated: May 26, 2022

CLINICAL TRIALS PROFILE FOR LIALDA


✉ Email this page to a colleague

« Back to Dashboard

All Clinical Trials for Lialda

Trial ID Title Status Sponsor Phase Start Date Summary
NCT00151892 ↗ Efficacy and Safety of SPD476 in Maintaining Remission in Patients With Ulcerative Colitis Completed Shire Phase 3 2005-04-08 Ulcerative colitis is a disease of the large bowel (colon) and rectum in which the lining of the bowel becomes red and swollen. Over time, patients with this disease may experience acute episodes of diarrhea, rectal bleeding and abdominal pain followed by periods of time without disease symptoms. 5-ASA drugs are a standard treatment for ulcerative colitis. Mesalazine is an experimental drug designed to gradually release 5-ASA into the areas of large bowel associated with ulcerative colitis. This study will test the safety and efficacy of mesalazine in keeping ulcerative colitis in remission.
NCT00446849 ↗ Strategies in Maintenance for Patients Receiving Long-term Therapy (S.I.M.P.L.E.) With MMX (Multi-Matrix System) Mesalamine for Ulcerative Colitis (UC) Completed Shire Phase 4 2007-05-01 To evaluate the percentage of subjects with clinical recurrence of UC at 6 months using MMX mesalamine once daily.
NCT00545103 ↗ Prevention of Recurrence of Diverticulitis Completed Shire Phase 3 2007-12-06 The purpose of this study is to determine whether SPD476 is effective in reducing recurrence of diverticulitis.
>Trial ID >Title >Status >Phase >Start Date >Summary

Clinical Trial Conditions for Lialda

Condition Name

Condition Name for Lialda
Intervention Trials
Ulcerative Colitis 6
Healthy 4
Colitis, Ulcerative 1
[disabled in preview] 0
This preview shows a limited data set
Subscribe for full access, or try a Trial

Condition MeSH

Condition MeSH for Lialda
Intervention Trials
Colitis, Ulcerative 6
Colitis 5
Ulcer 5
[disabled in preview] 0
This preview shows a limited data set
Subscribe for full access, or try a Trial

Clinical Trial Locations for Lialda

Trials by Country

Trials by Country for Lialda
Location Trials
United States 105
Canada 13
India 11
South Africa 9
Brazil 8
This preview shows a limited data set
Subscribe for full access, or try a Trial

Trials by US State

Trials by US State for Lialda
Location Trials
Florida 7
Georgia 5
Pennsylvania 5
Maryland 5
Kansas 5
This preview shows a limited data set
Subscribe for full access, or try a Trial

Clinical Trial Progress for Lialda

Clinical Trial Phase

Clinical Trial Phase for Lialda
Clinical Trial Phase Trials
Phase 4 3
Phase 3 4
Phase 2 1
[disabled in preview] 0
This preview shows a limited data set
Subscribe for full access, or try a Trial

Clinical Trial Status

Clinical Trial Status for Lialda
Clinical Trial Phase Trials
Completed 12
Terminated 1
[disabled in preview] 0
This preview shows a limited data set
Subscribe for full access, or try a Trial

Clinical Trial Sponsors for Lialda

Sponsor Name

Sponsor Name for Lialda
Sponsor Trials
Shire 9
National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) 1
James Lewis 1
[disabled in preview] 0
This preview shows a limited data set
Subscribe for full access, or try a Trial

Sponsor Type

Sponsor Type for Lialda
Sponsor Trials
Industry 11
Other 4
NIH 1
[disabled in preview] 0
This preview shows a limited data set
Subscribe for full access, or try a Trial

Make Better Decisions: Try a trial or see plans & pricing

Serving leading biopharmaceutical companies globally:

Colorcon
McKesson
Moodys
McKinsey
Harvard Business School
Boehringer Ingelheim

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.